Published May 20, 2021
| Version v1
Dataset
Open
Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
Description
This report describes the most relevant results of screening a drug repurposing library consisting of ~5500 FDA-approved drugs and clinical candidates that have passed phase I studies for activity against SARS-CoV-2.
Files
Files
(229.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6dd890e850a79694bb06482e5d3a4c17
|
229.1 kB | Download |